BackApimeds Pharmaceuticals US Overview

Apimeds Pharmaceuticals US Other Income Expense Net

Other Income/Expense Net for APUS.

Quarterly Other Income/Expense

-$22.87M
↓ 60049.25% YoY

As of Mar 31, 2026

Annual Other Income/Expense (TTM)

-$16.92M
↓ 13104.17% YoY

Trailing 12 months ending Mar 31, 2026

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin